drugset / Trial / NCT00812994

Neurotrophic Factors and Depression

NCT00812994

Phase 4 Completed 30 enrolled University of California, San Francisco
Double-blindBasic science

Summary

Study intended to determine if there are baseline differences in serum neurosteroid levels and neurotrophic factor (BDNF) levels in healthy controls vs unmedicated depressed subjects, and whether the levels of these change with antidepressant treatment. Study also intended to determine if baseline neurosteroid/ BDNF levels, and the change in these levels with =treatment, are correlated with clinical antidepressant response to escitalopram (Lexapro).

Timeline

Start
2003-01
Primary completion
2006-12
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg

Indications